Endocyte Inc (ECYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -55,064 | -43,888 | -41,270 | 5,460 | -18,032 |
| Depreciation Amortization | 761 | 1,315 | 2,197 | 2,472 | 1,921 |
| Accounts receivable | 1 | 192 | 856 | 5,491 | -2,509 |
| Accounts payable and accrued liabilities | -1,025 | -253 | -61 | -3,700 | -386 |
| Other Working Capital | -172 | -1,400 | -128 | -58,169 | -41,030 |
| Other Operating Activity | 21,840 | 9,383 | 6,187 | 6,241 | 8,956 |
| Operating Cash Flow | $-33,659 | $-34,651 | $-32,218 | $-42,206 | $-51,081 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -67 | -714 | -342 | -1,492 | -828 |
| Purchase Of Investment | -106,725 | -139,932 | -86,282 | -149,371 | -125,027 |
| Sale Of Investment | 134,930 | 190,765 | 88,114 | 82,302 | 195,147 |
| Other Investing Activity | -12,771 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $15,368 | $50,119 | $1,491 | $-68,560 | $69,292 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,716 | 493 | 684 | 103,495 | 645 |
| Common Stock Repurchased | -95 | -165 | -57 | -4 | N/A |
| Financing Cash Flow | $5,622 | $329 | $627 | $103,491 | $645 |
| Exchange Rate Effect | N/A | N/A | -1 | -39 | -7 |
| Beginning Cash Position | 31,228 | 15,432 | 45,533 | 52,847 | 33,997 |
| End Cash Position | 18,559 | 31,228 | 15,432 | 45,533 | 52,847 |
| Net Cash Flow | $-12,669 | $15,797 | $-30,102 | $-7,314 | $18,850 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,659 | -34,651 | -32,218 | -42,206 | -51,081 |
| Capital Expenditure | -83 | -714 | -342 | -1,502 | -828 |
| Free Cash Flow | -33,741 | -35,365 | -32,560 | -43,708 | -51,908 |